|
|
Blood, 15 July 2005, Vol. 106, No. 2, pp. 485-493.
Prepublished online as a Blood First Edition Paper on March 29, 2005; DOI 10.1182/blood-2004-10-4145.
Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Transforming growth factor- 1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12
Sunanda Basu, and
Hal E. Broxmeyer
From the Department of Microbiology and Immunology, the Walther Oncology Center, Indiana University School of Medicine, Indianapolis; and the Walther Cancer Institute, Indianapolis.
Disruption of stromal cell-derived factor-1 (SDF-1/CXCL12 [CXC chemokine ligand 12]) interaction leads to mobilization of stem/progenitor cells from bone marrow to circulation. However, prolonged exposure of CD34+ cells to SDF-1 desensitizes them to SDF-1. So how do cells remain responsive to SDF-1 in vivo when they are continuously exposed to SDF-1? We hypothesized that one or more mechanisms mediated by cytokines exist that could modulate SDF-1 responsiveness of CD34+ cells and the desensitization process. We considered transforming growth factor- 1 (TGF- 1) a possible candidate, since TGF- 1 has effects on CD34+ cells and is produced by stromal cells, which provide niches for maintenance and proliferation of stem/progenitor cells. TGF- 1 significantly restored SDF-1induced chemotaxis and sustained adhesion responses in cord blood CD34+ cells preexposed to SDF-1. Effects of TGF- 1 were dependent on the dose and duration of TGF- 1 pretreatment. Phosphorylation of extracellular signal-regulated kinase 1 (Erk1)/Erk2 was implicated in TGF- 1 modulation of migratory and adhesion responses to SDF-1. Our results indicate that low levels of TGF- 1 can modulate SDF-1 responsiveness of CD34+ cells and thus may facilitate SDF-1mediated retention and nurturing of stem/progenitor cells in bone marrow.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Basu, N. T. Ray, S. J. Atkinson, and H. E. Broxmeyer
Protein Phosphatase 2A Plays an Important Role in Stromal Cell-Derived Factor-1/CXC Chemokine Ligand 12-Mediated Migration and Adhesion of CD34+ Cells
J. Immunol.,
September 1, 2007;
179(5):
3075 - 3085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Li, S. Basu, M.-K. Han, Y.-J. Kim, and H. E. Broxmeyer
Influence of ERK activation on decreased chemotaxis of mature human cord blood monocyte-derived dendritic cells to CCL19 and CXCL12
Blood,
April 15, 2007;
109(8):
3173 - 3176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nakayama, N. Mutsuga, and G. Tosato
Effect of Fibroblast Growth Factor 2 on Stromal Cell-Derived Factor 1 Production by Bone Marrow Stromal Cells and Hematopoiesis
J Natl Cancer Inst,
February 7, 2007;
99(3):
223 - 235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yang, E. Jackson, B. M. Woerner, A. Perry, D. Piwnica-Worms, and J. B. Rubin
Blocking CXCR4-Mediated Cyclic AMP Suppression Inhibits Brain Tumor Growth In vivo
Cancer Res.,
January 15, 2007;
67(2):
651 - 658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Schatteman, M. Dunnwald, and C. Jiao
Biology of bone marrow-derived endothelial cell precursors
Am J Physiol Heart Circ Physiol,
January 1, 2007;
292(1):
H1 - H18.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|